
Releases
Evotec and Odyssey Therapeutics Partner on AI-Driven Drug Discovery
Evotec SE and Odyssey Therapeutics have launched a strategic R&D collaboration aimed at accelerating the discovery of small molecule treatments for autoimmune and inflammatory diseases, leveraging Evotec’s AI-enabled platform to identify validated hit series for high-value biological targets.







:format(jpg)/f.elconfidencial.com%2Foriginal%2F6bb%2Fd2d%2F5e3%2F6bbd2d5e3af41de5087139fb67158276.jpg)















